Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU1-68P (RNA, U1 small nuclear 68, pseudogene) is a human pseudogene belonging to the U1 small nuclear RNA (snRNA) gene family[2][4][5]. Unlike functional U1 snRNA genes (such as RNU1-1 or RNU1-2), which encode components of the spliceosomal machinery essential for pre-mRNA splicing, RNU1-68P does not encode a functional RNA molecule and is not incorporated into the spliceosome. There is no evidence that RNU1-68P is transcribed or expressed as a functional RNA in cells, nor does it participate in RNA processing or other regulatory functions. It is not considered a biological target for drugs or therapeutic intervention, and there are no known associations with disease, biomarkers, or adverse effects. RNU1-68P is cataloged chiefly in genomic databases for annotation and homology purposes, consistent with the typical role of pseudogenes in the human genome[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 68, pseudogene (RNU1-68P).